The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study
Article in Biomedicines (June 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Biomedicines (June 2024)
Article in Journal of Hepatocellular Carcinoma (June 2024)
Preprint in Research Square (May 2024)